Kid-size doses of Pfizer's COVID-19 vaccine appear safe and nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
[
add
]
[
|
|
...
]